These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 20667665

  • 1. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
    Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, Paterlini-Brechot P, Tiollais P.
    Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis.
    Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C.
    Oncogene; 2006 Jun 26; 25(27):3823-33. PubMed ID: 16799624
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 26; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
    Tseng TC, Liu CJ, Chen PJ, Lai MY, Lin CL, Kao JH, Chen DS.
    Liver Int; 2007 Sep 26; 27(7):983-8. PubMed ID: 17696938
    [Abstract] [Full Text] [Related]

  • 8. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Sep 26; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
    Bréchot C, Minami M, De Mitri S, Paterlini P.
    Princess Takamatsu Symp; 1995 Sep 26; 25():199-209. PubMed ID: 8875625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group.
    Gastroenterology; 2010 May 26; 138(5):1747-54. PubMed ID: 20114048
    [Abstract] [Full Text] [Related]

  • 13. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 26; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 26; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai S, Yachi A.
    Hepatogastroenterology; 1994 Oct 26; 41(5):438-41. PubMed ID: 7531667
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B and C virus-related carcinogenesis.
    Fung J, Lai CL, Yuen MF.
    Clin Microbiol Infect; 2009 Nov 26; 15(11):964-70. PubMed ID: 19874379
    [Abstract] [Full Text] [Related]

  • 18. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Dramé B, London WT.
    Cancer Epidemiol Biomarkers Prev; 1998 Jul 26; 7(7):559-65. PubMed ID: 9681522
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.
    J Gastroenterol Hepatol; 2007 Nov 26; 22(11):1921-8. PubMed ID: 17914971
    [Abstract] [Full Text] [Related]

  • 20. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 26; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.